Vertex Pharmaceuticals Incorporated shares owned by Berkshire Asset Management
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Berkshire Asset Management
from 13F filings
Historical chart of Berkshire Asset Management investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Berkshire Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Vertex Pharmaceuticals Incorporated by Berkshire Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $2.0M | 4.9k | 406.89 |
2023-09-30 | $1.7M | 4.9k | 347.74 |
2023-06-30 | $1.7M | 4.9k | 351.91 |
2023-03-31 | $1.5M | 4.8k | 315.07 |
2022-09-30 | $1.4M | 5.0k | 289.60 |
2022-06-30 | $1.7M | 6.1k | 281.85 |
2022-03-31 | $1.9M | 7.3k | 260.97 |
2021-12-31 | $2.2M | 10k | 219.60 |
2021-09-30 | $1.8M | 10k | 181.41 |
2021-06-30 | $2.1M | 10k | 201.62 |
2021-03-31 | $2.5M | 11k | 214.90 |
2020-12-31 | $1.7M | 7.3k | 236.28 |
2020-09-30 | $754k | 2.8k | 272.10 |
2020-06-30 | $700k | 2.4k | 290.34 |
2020-03-31 | $1.2M | 5.1k | 237.98 |
2019-12-31 | $386k | 1.8k | 218.70 |
2019-09-30 | $307k | 1.8k | 169.24 |
2019-06-30 | $333k | 1.8k | 183.57 |
2019-03-31 | $269k | 1.5k | 183.87 |
2018-12-31 | $242k | 1.5k | 165.41 |
2018-09-30 | $359k | 1.9k | 192.70 |
2018-06-30 | $317k | 1.9k | 170.16 |
2018-03-31 | $304k | 1.9k | 163.18 |
2017-12-31 | $279k | 1.9k | 149.76 |
2017-09-30 | $287k | 1.9k | 151.93 |
2017-06-30 | $240k | 1.9k | 128.82 |
2017-03-31 | $233k | 2.1k | 109.29 |
2015-12-31 | $216k | 1.7k | 126.09 |
2015-06-30 | $224k | 1.8k | 123.55 |
2015-03-31 | $214k | 1.8k | 118.04 |
2014-12-31 | $295k | 2.5k | 118.76 |
2014-09-30 | $279k | 2.5k | 112.32 |
2014-06-30 | $235k | 2.5k | 94.61 |
More positions owned by Berkshire Asset Management
View all positions for Berkshire Asset Management
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated